The Australian Commission on Safety and Quality in Health Care released an updated Stroke Clinical Care Standard on 11 June 2026, replacing the Acute Stroke Clinical Care Standard (2019). The Commission lists the change of title as the first of its revisions, saying the standard now covers aspects of care extending beyond the acute and hyperacute phase, and it restates the goal as improving the assessment, management and transitions of care for patients with stroke. Within the rehabilitation content, the Commission directs that throughout the hospital admission the multidisciplinary team should continually reassess the patient's rehabilitation needs, especially before discharge, and should consider changes in mood and cognition such as difficulty with concentration, memory loss and language issues, documenting those assessments in the medical record and discussing ongoing care with patients, their families and support people. At follow-up, the standard lists cognition alongside vision, fitness to drive, continence and equipment needs, and asks that mood be reassessed.
That placement matters because of how these documents are used. The Commission states that Clinical Care Standards play a role in the accreditation of healthcare services assessed to the National Safety and Quality Health Service Standards and to the National Safety and Quality Primary and Community Healthcare Standards, and that services are expected to identify relevant Clinical Care Standards and implement those that will reduce risk, improve quality and address local areas of unwarranted variation. Under the Clinical Governance Standard, services are expected to support clinicians to use the best available evidence, including clinical care standards, and to monitor and respond to unwarranted clinical variation. Cognition after stroke, previously a matter for guideline advice, now sits inside a document that assessors look at.
The standard was first released in 2015 with a minor update in 2019, and the Commission says the 2026 version incorporates changes in the relevant evidence-based guidelines since then. Other listed changes include cultural safety and equity considerations, broader inclusion of stroke telehealth in hyperacute and acute care, greater emphasis on ambulance services and pre-hospital notification, time-critical care for intracerebral haemorrhage, and greater emphasis on rehabilitation, including assessment of needs, initiation in hospital and planning for care after discharge. Lee Fong, a general practitioner and medical adviser to the Commission, said of the update, in remarks reported by Pharmacy Daily on the day of release, that "People may need help with speech, memory, energy, mental health, eating and drinking, as well as movement."
The contrast with the parallel guideline process is instructive. The Australian and New Zealand living stroke guidelines, run by the Stroke Foundation and approved in stages by the National Health and Medical Research Council, ran a public consultation on draft recommendations from 9am on 27 May 2026 to 5pm on 1 July 2026; the item posted for that round was a wording adjustment to the strong recommendation against platelet transfusion in intracerebral haemorrhage for patients on prior antiplatelet therapy, not anything about cognition. The guidelines move one recommendation at a time as evidence arrives; the care standard sets the service-level expectation. Neither document is a blanket mandate: the Commission's own framing is that services implement the standards relevant to their scope and risk, so how consistently the cognition wording is acted on, and with what tools, will vary by hospital.